Fuling Technology
001356
KLT
831689
Hand Enterprise Solutions
300170
4
GRANDTECH
835184
5
Doushen(Beijing) Education & Technology Inc.
300010
US Stock MarketDetailed Quotes
MBX MBX Biosciences
- 11.730
- +0.880+8.11%
Close Jan 23 16:00 ET
- 12.430
- +0.700+5.97%
Post 17:28 ET
391.99MMarket Cap-7.10P/E (TTM)
12.210High10.640Low547.26KVolume10.830Open10.850Pre Close6.08MTurnover5.37%Turnover RatioLossP/E (Static)33.42MShares27.50052wk High1.44P/B119.65MFloat Cap9.42452wk Low--Dividend TTM10.20MShs Float27.500Historical High--Div YieldTTM14.47%Amplitude9.424Historical Low11.115Avg Price1Lot Size
About MBX Biosciences Company
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.
Company Profile
SymbolMBX
Company NameMBX Biosciences
Listing DateSep 13, 2024
Issue Price16.00
Founded2018
CEOMr. Peter Kent Hawryluk
MarketNASDAQ
Employees36
Fiscal Year Ends12-31
Address11711 North Meridian Street,Suite 300
CityCarmel
ProvinceIndiana
CountryUnited States of America
Zip Code46032
Phone1-317-659-0200
Websitehttp://www.mbxbio.com
Company Executives
- Name
- Position
- Salary
- Peter Kent Hawryluk
- President, Chief Executive Officer and Director
- 4.86M
- Dr. Salomon Azoulay, M.D.
- Chief Medical Officer
- --
- Richard B. Bartram
- Chief Financial Officer and Principal Accounting Officer
- 1.05M
- Dr. Tiba Aynechi, PhD
- Independent Director
- --
- Dr. Steven Ryder, M.D.
- Independent Director
- --
- Dr. Carl L. Gordon, C.F.A.,PhD
- Independent Director
- --
- Patrick J. Heron
- Independent Director
- --
- James M. Cornelius
- Independent Director
- --
- Edward T. Mathers
- Independent Director
- --
- Dr. Ora H. Pescovitz, M.D.
- Independent Director
- --
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
U.S.-China talks spark interest, no more inflation?
🎙️Discussion: 1. How will Trump's China policies affect Chinese assets? 2. Which sectors might benefit as U.S. inflation risks decline?
Moomoo News Global
Dec 9, 2024 20:23
China Will Adopt a "Moderately Accommodative" Monetary Policy in the Next Year, The First Shift to Easing Since 2011